These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1959444)

  • 41. A bait and switch hapten strategy generates catalytic antibodies for phosphodiester hydrolysis.
    Wentworth P; Liu Y; Wentworth AD; Fan P; Foley MJ; Janda KD
    Proc Natl Acad Sci U S A; 1998 May; 95(11):5971-5. PubMed ID: 9600901
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A catalytic antibody against a tocopherol cyclase inhibitor.
    Manetsch R; Zheng L; Reymond MT; Woggon WD; Reymond JL
    Chemistry; 2004 May; 10(10):2487-506. PubMed ID: 15146522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Innate antibody catalysis.
    Gololobov G; Sun M; Paul S
    Mol Immunol; 1999 Dec; 36(18):1215-22. PubMed ID: 10684961
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of the antigen combining site: correlations between length and sequence composition of the hypervariable loops and the nature of the antigen.
    Collis AV; Brouwer AP; Martin AC
    J Mol Biol; 2003 Jan; 325(2):337-54. PubMed ID: 12488099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structure and specificity of the anti-digoxin antibody 40-50.
    Jeffrey PD; Schildbach JF; Chang CY; Kussie PH; Margolies MN; Sheriff S
    J Mol Biol; 1995 Apr; 248(2):344-60. PubMed ID: 7739045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Routes to catalysis: structure of a catalytic antibody and comparison with its natural counterpart.
    Haynes MR; Stura EA; Hilvert D; Wilson IA
    Science; 1994 Feb; 263(5147):646-52. PubMed ID: 8303271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toward bifunctional antibody catalysis.
    Kikuchi K; Hannak RB; Guo MJ; Kirby AJ; Hilvert D
    Bioorg Med Chem; 2006 Sep; 14(18):6189-96. PubMed ID: 16782349
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunological optimization of a generic hydrophobic pocket for high affinity hapten binding and Diels-Alder activity.
    Piatesi A; Hilvert D
    Chembiochem; 2004 Apr; 5(4):460-6. PubMed ID: 15185369
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Broadly distributed chemical reactivity of natural antibodies expressed in coordination with specific antigen binding activity.
    Planque S; Taguchi H; Burr G; Bhatia G; Karle S; Zhou YX; Nishiyama Y; Paul S
    J Biol Chem; 2003 May; 278(22):20436-43. PubMed ID: 12668670
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Crystal structure of a catalytic antibody with a serine protease active site.
    Zhou GW; Guo J; Huang W; Fletterick RJ; Scanlan TS
    Science; 1994 Aug; 265(5175):1059-64. PubMed ID: 8066444
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mapping and modification of an antibody hapten binding site: a site-directed mutagenesis study of McPC603.
    Glockshuber R; Stadlmüller J; Plückthun A
    Biochemistry; 1991 Mar; 30(12):3049-54. PubMed ID: 1901023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-bromosuccinimide oxidation of anti-DNP and anti-DNP-p-aminobenzoylglutamate antibodies in the presence and absence of protecting hapten.
    Chism GE; Woehler ME; Lovins RE
    Immunology; 1975 Dec; 29(6):1153-60. PubMed ID: 1193686
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunological origins of binding and catalysis in a Diels-Alderase antibody.
    Romesberg FE; Spiller B; Schultz PG; Stevens RC
    Science; 1998 Mar; 279(5358):1929-33. PubMed ID: 9506942
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination.
    Wenthur CJ; Cai X; Ellis BA; Janda KD
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3666-3668. PubMed ID: 28709828
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combining site specificity of monoclonal antibodies to the organophosphate hapten soman.
    Buenafe AC; Rittenberg MB
    Mol Immunol; 1987 May; 24(5):401-7. PubMed ID: 3657786
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of conserved amino acid residues in the complementarity determining regions on hapten-antibody interaction of anti-(4-hydroxy-3-nitrophenyl) acetyl antibodies.
    Taketani M; Naitoh A; Motoyama N; Azuma T
    Mol Immunol; 1995 Sep; 32(13):983-90. PubMed ID: 7477004
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A structural basis for transition-state stabilization in antibody-catalyzed hydrolysis: crystal structures of an abzyme at 1. 8 A resolution.
    Kristensen O; Vassylyev DG; Tanaka F; Morikawa K; Fujii I
    J Mol Biol; 1998 Aug; 281(3):501-11. PubMed ID: 9698565
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combining Yeast Display and Competitive FACS to Select Rare Hapten-Specific Clones from Recombinant Antibody Libraries.
    Sun Y; Ban B; Bradbury A; Ansari GA; Blake DA
    Anal Chem; 2016 Sep; 88(18):9181-9. PubMed ID: 27571429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Photochemical linking of primary aromatic amines to carrier proteins to elicit antibody response against the amine haptens.
    Pandey RN; Davis LE; Anderson B; Hollenberg PF
    J Immunol Methods; 1986 Nov; 94(1-2):237-46. PubMed ID: 3782813
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Separation of normal and immune lymphoid cells by antigen-coated coated columns. Antigen-binding characteristics of membrane antibodies as analyzed by hapten-protein antigens.
    Wigzell H; Mäkelä O
    J Exp Med; 1970 Jul; 132(1):110-26. PubMed ID: 4927594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.